The U.S. Food and Drug Administration’s approval of Viz.ai’s hypertrophic cardiomyopathy establishes a new category for cardiovascular machine learning-based notification software.
WHY IT MATTERS
Viz.ai, a disease detection and intelligent care coordination company, said in its announcement…
Source: Healthcareitnews.com and Read More
WhatsApp 0-Day Vulnerability Exploited to Hack Mac and iOS Users
A sophisticated attack campaign has leveraged a previously unknown zero-day vulnerability in WhatsApp on Apple devices to target specific users, the company has confirmed. The
